Inari Medical is a commercial-stage medical device company. Co. is engaged in the development, manufacturing, marketing and selling of devices for the interventional treatment of venous diseases. Co. offers catheter-based technologies for the treatment of venous thromboembolism. Co. also develops solutions that enables the safe removal of clot volumes from big vessels without the use of thrombolytic drugs. Co.'s development products include ClotTriever (a mechanical thrombectomy system) and FlowTriever (a bore catheter-based aspiration and mechanical thrombectomy system). The NARI stock yearly return is shown above.
The yearly return on the NARI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NARI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|